World's Best Scientists 2026 revealed!
Award Badge
Immunology
Belgium
2026

D-Index & Metrics

Immunology

D-Index
109
Citations
38066
World Ranking
524
National Ranking
4

Medicine

D-Index
109
Citations
38425
World Ranking
5825
National Ranking
61

Michel Goldman publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michel Goldman sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 682 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Michel Goldman D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michel Goldman sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 109 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in Belgium Leader Award
  • 2025 - Research.com Immunology in Belgium Leader Award
  • 2023 - Research.com Immunology in Belgium Leader Award
  • 2022 - Research.com Immunology in Belgium Leader Award

Overview

Michel Goldman is affiliated with the Université Libre de Bruxelles in Belgium and has an extensive research portfolio primarily in the field of medicine. Their work spans various subfields including infectious diseases, surgery, neurology, oncology, and molecular biology.

Their main research interests cover topics such as the long-term effects of COVID-19, lymphadenopathy diagnosis and analysis, COVID-19 clinical research studies, SARS-CoV-2 and COVID-19 research, inflammasome and immune disorders, lymphoma diagnosis and treatment, and heparin-induced thrombocytopenia and thrombosis.

Michel Goldman has published recent papers including:

  • "Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies" (2021, Autoimmunity Reviews)
  • "Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report" (2021, Frontiers in Medicine)
  • "Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunity" (2021, PLoS Medicine)
  • "Online Information on Probiotics: Does It Match Scientific Evidence?" (2020, Frontiers in Medicine)
  • "Long Covid, a great imitator of the 21th century" (2022, Frontiers in Medicine)

The scientist frequently collaborates with co-authors including Marie Neunez, Serge Goldman, Elie Cogan, Dominique Bron, and Thomas Tousseyn.

Michel Goldman's publications often appear in venues such as Frontiers in Medicine, SSRN Electronic Journal, Frontiers for Young Minds, Autoimmunity Reviews, and PLoS Medicine.

In addition to journal articles, Michel Goldman has authored a book titled Le coronavirus et ces microbes qu'il nous faut combattre, première édition, published by Frontiers Media in 2022.

Best Publications

  • Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.

    Bart Keymeulen;Evy Vandemeulebroucke;Anette G. Ziegler;Chantal Mathieu

  • Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.

    C. Gérard;C Bruyns;Arnaud Marchant;Daniel Abramowicz

  • Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans

    Pervinder Sagoo;Esperanza Perucha;Birgit Sawitzki;Stefan Tomiuk

  • Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes

    Fabienne Willems;Arnaud Marchant;Jean-Pierre Delville;Catherine Gérard

  • Interleukin-10 production during septicaemia

    A. Marchant;M. Goldman;J. Devière;B. Byl

  • Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway.

    Valérie Verhasselt;Christel Buelens;Fabienne Willems;Donat De Groote

  • Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients.

    Daniel Abramowicz;Liliane Schandene;Michel Goldman;Alain Crusiaux

  • TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity.

    Michel Goldman;Philippe Druet;Ernst Gleichmann

  • Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction.

    L. A. B. Joosten;E. Lubberts;P. Durez;M. M. A. Helsen

  • Vaccination and autoimmune disease: what is the evidence?

    David C Wraith;Michel Goldman;Paul-Henri Lambert

  • Brief report: Clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome

    Elie Cogan;Liliane Schandene;Alain Crusiaux;Pascale Cochaux

  • IL-10 Is an Important Mediator of the Enhanced Susceptibility to Pneumococcal Pneumonia after Influenza Infection

    Koenraad F. van der Sluijs;Leontine J. R. van Elden;Monique Nijhuis;Rob Schuurman

  • Deficient IL-12(p35) Gene Expression by Dendritic Cells Derived from Neonatal Monocytes

    Stanislas Goriely;Benoı̂t Vincart;Patrick Stordeur;Johan Vekemans

  • Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells.

    Christel Buelens;Fabienne Willems;Anne Delvaux;Géraldine Pierard

  • Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion.

    S Dubucquoi;P Desreumaux;A Janin;O Klein

  • Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia.

    Arnaud Marchant;Catherine Bruyns;Peter Vandenabeele;Martine Ducarme

  • Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma.

    S Wadler;E L Schwartz;M Goldman;A Lyver

  • Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice

    Hubert Louis;Jean-Luc Van Laethem;Wei Wu;Eric Quertinmont

  • Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor

    Christel Buelens;Valérie Verhasselt;Donat De Groote;Kris M. Thielemans

  • B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10.

    Liliane Schandené;Cristina Alonso-Vega;Fabienne Willems;C. Gérard

  • Interleukin-10: actions and therapeutic potential.

    Michel Goldman;Thierry Velu;Marina Pretolani

Frequent Co-Authors

Fabienne Willems
Fabienne Willems Université Libre de Bruxelles
Arnaud Marchant
Arnaud Marchant Université Libre de Bruxelles
Stanislas Goriely
Stanislas Goriely Université Libre de Bruxelles
Oberdan Leo
Oberdan Leo Université Libre de Bruxelles
Peter Vandenabeele
Peter Vandenabeele Ghent University
Paul-Henri Lambert
Paul-Henri Lambert University of Geneva
Sandrine Florquin
Sandrine Florquin University of Amsterdam
Kris Thielemans
Kris Thielemans Vrije Universiteit Brussel
Maria-Luisa Alegre
Maria-Luisa Alegre University of Chicago
Muriel Moser
Muriel Moser Université Libre de Bruxelles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Immunology in the USA opens doors to various related healthcare careers, many of which can be enhanced through online education. For those interested in nursing but coming from non-nursing backgrounds, 12-month accelerated nursing programs online for non nurses provide an excellent pathway to transition quickly into the nursing field while building a strong foundation in patient care and immune system health.

If you're seeking a faster route into registered nursing, exploring 12-month accelerated nursing programs can be beneficial. These programs cater to driven students aiming for rapid completion without compromising essential clinical training relevant to immunology applications.

For those interested in practical nursing roles, easy lpn programs to get into offer accessible entry points. Licensed Practical Nurses often work alongside immunologists in clinical settings, making it a viable pathway to support and understand immune-related healthcare.

Advancing further, easiest nurse practitioner degree programs provide options to gain advanced practice credentials, enabling direct patient diagnosis and treatment in immunology-focused specialties. This pathway is ideal for those looking to deepen their impact on patient immune health.

Best Scientists Citing Michel Goldman

Trending Scientists